4cps-069 Evaluation of Palivizumab as Prophylaxis Against Respiratory Syncytial Virus Infection
doi 10.1136/ejhpharm-2020-eahpconf.170
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2020
Authors
Publisher
British Medical Journal Publishing Group